Artificial Intelligence For Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview Q2 2018 - Bharat Book Bureau -Market Research Reports - 0 views
-
aado lfst01 on 23 Aug 18Artificial Intelligence For Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview Q2/2018 offers comprehensive coverage of the current state of the AI in Drug Discovery industry landscape, featuring chapters on the history, current state and near future of the industry, regional and subsector-specific competutive and comparative analyses, and profiles of 100 Companies, 220 Investors, 15 Biopharma, 15 IT/Tech Corporations, and 20 leading R&D Centres active in the AI for Drug Discovery space.